Study links dapagliflozin to bladder, breast cancers

06/26/2011 | Reuters

Patients treated with the diabetes drug dapagliflozin may develop certain types of cancer, according to company reports from Bristol-Myers Squibb and AstraZeneca, co-makers of the drug. About nine bladder cancer and nine breast cancer incidences were noted in participants on dapagliflozin therapy, experts said.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN